company background image
2877 logo

China Shineway Pharmaceutical Group SEHK:2877 Stok Raporu

Son Fiyat

HK$8.13

Piyasa Değeri

HK$6.1b

7D

-3.3%

1Y

15.2%

Güncellenmiş

23 Nov, 2024

Veri

Şirket Finansalları +

China Shineway Pharmaceutical Group Limited

SEHK:2877 Stok Raporu

Piyasa değeri: HK$6.1b

2877 Stoklara Genel Bakış

Bir yatırım holding şirketi olan China Shineway Pharmaceutical Group Limited, Çin Halk Cumhuriyeti ve Hong Kong'da Çin ilaçlarının araştırma ve geliştirme, üretim ve ticaretini yapmaktadır. Daha fazla detay

China Shineway Pharmaceutical Group Limited Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti China Shineway Pharmaceutical Group
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıHK$8.13
52 Haftanın En Yüksek SeviyesiHK$10.72
52 Haftanın En Düşük SeviyesiHK$6.61
Beta0.81
11 Aylık Değişim-13.88%
3 Aylık Değişim0.74%
1 Yıllık Değişim15.16%
33 Yıllık Değişim14.83%
5 Yıllık Değişim1.25%
Halka arzdan bu yana değişim68.50%

Son Haberler & Güncellemeler

China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Oct 18
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Recent updates

China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Oct 18
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Jun 03
If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?

May 13
Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?

China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461

Apr 26
China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461

Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?

Apr 17
Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?

China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461

Mar 31
China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461

China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings

Mar 14
China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings

Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

Jan 29
Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly

Sep 28
China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly

China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118

Sep 01
China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118

We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Aug 03
We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?

May 30
Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?

We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Mar 07
We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125

Sep 01
China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125

China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 31
China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet

Apr 07
China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet

China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.

Mar 11
China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.

Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?

Feb 18
Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?

Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?

Jan 31
Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?

Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?

Jan 13
Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?

What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?

Dec 25
What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?

We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease

Dec 10
We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease

Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years

Nov 25
Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years

Hissedar Getirileri

2877HK PharmaceuticalsHK Pazar
7D-3.3%0.07%-0.6%
1Y15.2%-10.2%9.6%

Getiri vs. Endüstri: 2877 geçen yıl % -10.2 oranında getiri sağlayan Hong Kong Pharmaceuticals sektörünü aştı.

Getiri vs Piyasa: 2877 geçen yıl % 9.6 oranında getiri sağlayan Hong Kong Piyasasını aştı.

Fiyat Oynaklığı

Is 2877's price volatile compared to industry and market?
2877 volatility
2877 Average Weekly Movement5.2%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement8.9%
10% most volatile stocks in HK Market19.2%
10% least volatile stocks in HK Market4.3%

İstikrarlı Hisse Senedi Fiyatı: 2877 son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: 2877 'nin haftalık oynaklığı ( 5% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
20023,232n/awww.shineway.com

Bir yatırım holding şirketi olan China Shineway Pharmaceutical Group Limited, Çin Halk Cumhuriyeti ve Hong Kong'da Çin ilaçlarının araştırma ve geliştirme, üretim ve ticaretini yapmaktadır. Şirket, enjeksiyon, yumuşak kapsül ve granül şeklinde Çin ilaçları; tablet, hap, oral sıvı ve toz ve solunum sistemi hastalığı, sinir sistemi, sindirim sistemi hastalığı, kardiyovasküler ve serebrovasküler, ortopedi, pediatri ve diğer alanlar dahil olmak üzere çeşitli terapötik alanlarda geleneksel Çin tıbbı granüllerinin yanı sıra vücudu güçlendirmek için ilaçlar sunmaktadır. Ayrıca tarım ürünleri ticareti ve Çin farmasötik ürünlerinin araştırma ve geliştirme faaliyetlerinde de bulunmaktadır.

China Shineway Pharmaceutical Group Limited Temel Bilgiler Özeti

China Shineway Pharmaceutical Group'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
2877 temel i̇stati̇sti̇kler
Piyasa değeriHK$6.14b
Kazançlar(TTM)HK$1.19b
Gelir(TTM)HK$4.52b

5.2x

F/K Oranı

1.4x

P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
2877 gelir tablosu (TTM)
GelirCN¥4.20b
Gelir MaliyetiCN¥1.04b
Brüt KârCN¥3.16b
Diğer GiderlerCN¥2.06b
KazançlarCN¥1.10b

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)1.46
Brüt Marj75.21%
Net Kâr Marjı26.27%
Borç/Özkaynak Oranı4.5%

2877 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

6.9%

Mevcut Temettü Verimi

37%

Ödeme Oranı